ANALYST REITERATES BUY ON SOME DRUG STOCKS
Merrill Lynch and Co analyst Richard
Vietor said he reiterated a buy recommendation on several drug
stocks today.
    The stocks were Bristol-Myers Co <BMY>, which rose 2-1/4 to
101, Schering-Plough Corp <SGP> 2-7/8 to 97 and Syntex Corp
<SYN> 1-3/8 to 82. Vietor described these stocks as a "middle
group" of performers.
    Vietor said the prices of these stocks, "look pretty cheap
relative to the leading performers in the drug group, such as
Upjohn Co <UPJ>, Merck and Co Inc <MRK>, and Squibb Corp
<SQB>."
    Vietor said he also mentioned Pfizer Inc <PFE> up two to
72-3/4 and Warner-Lambert Co <WLA> up 1-1/2 to 74-1/2 as being
in the middle group. But he did not recommend those stocks,
which he rates as neutral.
                                       
 Reuter
